Publication dates

Antibody Industry, July 2014 Market Reports from Top Publishers

You might be interested in: flow cytometry, diagnostic, disease testing, more »


 
1-10 of about 200 reports for Antibody

Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... antibodies in oncology drug pipeline update 2014 the commercial and therapeutic success of antibodies like rituxan, avastin, and erbitux will force the industry to look into the next generation ...

Antibodies in Oncology: Drug Pathway Analyzer 2014

Antibodies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... According to your pipeline specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any antibody drug ...

Anti GM-CSF Antibody -Pipeline Insights, 2014

Anti GM-CSF Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... This mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti gm-csf antibody. This report provides information on the therapeutic ...

Anti-CD105 Antibody -Pipeline Insights, 2014

Anti-CD105 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... This mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti-cd105 antibody. This report provides information on the therapeutic ...

Anti-CD152 Antibody -Pipeline Insights, 2014

Anti-CD152 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... This mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti-cd152 antibody. This report provides information on the therapeutic ...

Anti-CD19 Antibody -Pipeline Insights, 2014

Anti-CD19 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... This mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti-cd19 antibody. This report provides information on the therapeutic ...

Anti-CD22 Antibody -Pipeline Insights, 2014

Anti-CD22 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... This mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti-cd22 antibody. This report provides information on the therapeutic ...

Anti-CD25 Antibody -Pipeline Insights, 2014

Anti-CD25 Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... This mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti-cd25 antibody. This report provides information on the therapeutic ...

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... Drugs across this mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti-cd274 (pd-l1) antibody. This report provides ...

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

... Across this mechanism of action (moa). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under anti-cd279 (pd-1) antibody. This report provides ...

About 4 200 reports for Antibody

Download Unlimited Documents from Trusted Public Sources

Antibody Industry in Poland

  • Seroprevalence of Diphtheria Toxoid Igg Antibodies in Children, ...
  • January 2012
    6 pages
  • Antibody  

  • Poland  

    Europe  

View report >

Allograft Statistics

January 2012

4 Companies for Antibody

Read our Company Profiles

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.